4.5 Article

Downregulation of lncRNA MEG3 is involved in Parkinson's disease

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

LncRNA-MEG3 inhibits cell proliferation of endometrial carcinoma by repressing Notch signaling

Qingyun Guo et al.

BIOMEDICINE & PHARMACOTHERAPY (2016)

Review Biochemistry & Molecular Biology

Circulating long non-coding RNAs in cancer: current status and future perspectives

Peng Qi et al.

MOLECULAR CANCER (2016)

Review Biochemistry & Molecular Biology

Long non-coding RNAs and cancer: a new frontier of translational research?

R. Spizzo et al.

ONCOGENE (2012)

Article Biochemistry & Molecular Biology

Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2

Xianming Deng et al.

NATURE CHEMICAL BIOLOGY (2011)

Review Genetics & Heredity

Non-coding RNAs in human disease

Manel Esteller

NATURE REVIEWS GENETICS (2011)

Review Physiology

WHAT GENETICS TELLS US ABOUT THE CAUSES AND MECHANISMS OF PARKINSON'S DISEASE

Olga Corti et al.

PHYSIOLOGICAL REVIEWS (2011)

Article Clinical Neurology

Visual Symptoms in Parkinson's Disease

R. A. Armstrong

PARKINSONS DISEASE (2011)

Review Oncology

Non-coding RNAs: regulators of disease

Ryan J. Taft et al.

JOURNAL OF PATHOLOGY (2010)

Article Neurosciences

The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease

Mark R. Cookson

NATURE REVIEWS NEUROSCIENCE (2010)

Review Genetics & Heredity

Long non-coding RNAs: insights into functions

Tim R. Mercer et al.

NATURE REVIEWS GENETICS (2009)

Article Biochemistry & Molecular Biology

Non-coding RNAs: the architects of eukaryotic complexity

JS Mattick

EMBO REPORTS (2001)